Filter by tags: United States South Africa CANDU reactor Clear all tag filters
2 news articles found
Medical isotopes are radioactive substances used in various diagnostic and therapeutic procedures to treat various types of cancers and other conditions. They are essential for modern medicine, allowing physicians to visualise and target specific organs, tissues and cells in a patient’s body.
Over more than a decade, personalised medicine using nuclear techniques has been gaining pace, allowing doctors to tailor therapies and treatments to the specific needs and physiology of a patient, and to avoid harm to healthy organs or tissues.
According to Sven Van den Berghe, chief executive of Belgium-based isotope producer PanTera, one technique that has seen significant advances is known as theranostics – the term used to describe the combination of using one radioactive drug to diagnose and a second to deliver therapy to treat the main tumour and any metastatic tumours.
- Source: Nucnet
- Date: Friday, 14 April 2023
- Original article: nucnet.org/news/sector-aims-to-tackle-isotope-supply-problems-as-excitement-grows-over-targeted-therapies-4-4-2023
South Africa says it has put aside ZAR200m ($14.7m) in preparation for its nuclear energy programme to ease pressure on growth caused by ongoing electricity shortages. "National Treasury is working with the Department of Energy to consider the costs, benefits and risks of building additional nuclear power stations," the treasury said in its medium term budget policy statement. South African Finance Minister Nhlanhla Nene has previously pledged that the nuclear programme will be transparent, answering concerns among opposition parties that the government is moving ahead without proper disclosure. South Africa has signed agreements with several countries as it starts its nuclear build programme to develop 9,600MWe of nuclear energy by 2030.
- Source: NEI Magazine
- Date: Saturday, 24 October 2015
- Original article: neimagazine.com/news/newssouth-africa-allocates-funds-for-nuclear-4700832